Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts

19 Aug 2022

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated August 8, 2022 wherein we have intimated the schedule of Investors/ Analysts call on August 12, 2022. We are attaching herewith the Transcript of the analyst / investor call on the Unaudited Financial Results of the Company for the first quarter ended June 30, 2022 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

12 Aug 2022

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Audio Recording Of Earnings Call Conducted On August 12, 2022

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated August 8, 2022, please note that the audio recording of the earnings call on the unaudited financial results for the first quarter ended June 30, 2022, held on August 12, 2022, at 8.30 AM (IST), has been uploaded on our website on the following web-link: https://www.aurobindo.com/wp-content/uploads/2022/08/audio1190421139.mp3

pdf

Aurobindo Pharma Ltd.

06 Jun 2022

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated May 26, 2022 wherein we have intimated the schedule of Investors/ Analysts call on May 31, 2022. We are attaching herewith the Transcript of the analyst / investor call on the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2022 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

31 May 2022, 06:05PM

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Audio Recording Of Earnings Call

BSE India

Pursuant to Regulation 30 of SEBI Listing Regulations, and further to our letter dated May 26, 2022, please note that the audio recording of the earnings call for the fourth quarter and financial year ended March 31, 2022, held on May 31, 2022, at 8.30 AM (IST) has been uploaded on our website on the following web-link: https://www.aurobindo.com/wp-content/uploads/2022/05/Aurobindo-Q4-.mp3

pdf

Aurobindo Pharma Ltd.

31 May 2022, 10:21AM

1139.80

-1.57%

Earnings Call for Q4FY22 of Aurobindo Pharma Ltd.

Conference Call with Aurobindo Pharma Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.

Aurobindo Pharma Ltd.

17 Feb 2022

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated February 3, 2022 wherein we have intimated the schedule of Investors/ Analysts call on February 10, 2022. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the third quarter and nine months period ended December 31, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

10 Feb 2022

1139.80

-1.57%

Earnings Call for Q3FY22 of Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.

audio

Aurobindo Pharma Ltd.

19 Nov 2021

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated November 2, 2021 wherein we have intimated the schedule of Investors/ Analysts call on November 9, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the second quarter and half year ended September 30, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd.

09 Nov 2021

1139.80

-1.57%

Earnings Call for Q2FY22 of Aurobindo Pharma

Conference Call with Aurobindo Pharma Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.

Aurobindo Pharma Ltd.

25 Aug 2021

1139.80

-1.57%

Earnings Call

AUROBINDO PHARMA LTD. - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Please refer to our letter dated August 7, 2021 wherein we have intimated the schedule of Investors/ Analysts call on August 13, 2021. We are attaching herewith the Transcript of the analyst / investor call on the Un-audited Financial Results of the Company for the first quarter ended June 30, 2021 and the same is being uploaded on the website of the Company and is available in the following web link. https://www.aurobindo.com/investors/results-reports-presentations/conference-call-transcripts/

pdf

Aurobindo Pharma Ltd. Conference Calls and Earnings Call Transcripts